Covered recipient · General Payments record
KEEGAN BRADY MECHELS
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2022–2023
$3,303.40
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $2,329.42 | 4 |
| Food and Beverage | $693.19 | 7 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $2,761.75 | 8 |
| Apellis Pharmaceuticals, Inc. | $228.47 | 2 |
| Alcon Laboratories Inc | $32.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $270.76 | 03/04/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 997892621 | CMS |
| ABBVIE INC. | $80.63 | 03/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997892623 | CMS |
| ABBVIE INC. | $39.50 | 03/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997892625 | CMS |
| ABBVIE INC. | $39.50 | 03/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997892627 | CMS |
| ABBVIE INC. | $675.74 | 03/04/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 997892629 | CMS |
| ABBVIE INC. | $1,199.38 | 03/04/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 997892631 | CMS |
| ABBVIE INC. | $272.70 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997892633 | CMS |
| ABBVIE INC. | $183.54 | 06/01/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 997892635 | CMS |
| Alcon Vision LLC | $32.39 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011644717 | CMS |
| Apellis Pharmaceuticals, Inc. | $103.48 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056331771 | CMS |
| Apellis Pharmaceuticals, Inc. | $124.99 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056376131 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.